Cargando…

Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes

Detalles Bibliográficos
Autores principales: Connell, C. M., Raby, S., Beh, I., Flint, T. R., Williams, E. H., Fearon, D. T., Jodrell, D. I., Janowitz, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834107/
https://www.ncbi.nlm.nih.gov/pubmed/28430855
http://dx.doi.org/10.1093/annonc/mdx181
_version_ 1783303591396638720
author Connell, C. M.
Raby, S.
Beh, I.
Flint, T. R.
Williams, E. H.
Fearon, D. T.
Jodrell, D. I.
Janowitz, T.
author_facet Connell, C. M.
Raby, S.
Beh, I.
Flint, T. R.
Williams, E. H.
Fearon, D. T.
Jodrell, D. I.
Janowitz, T.
author_sort Connell, C. M.
collection PubMed
description
format Online
Article
Text
id pubmed-5834107
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58341072018-03-07 Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes Connell, C. M. Raby, S. Beh, I. Flint, T. R. Williams, E. H. Fearon, D. T. Jodrell, D. I. Janowitz, T. Ann Oncol Letters to the Editor Oxford University Press 2017-07 2017-04-14 /pmc/articles/PMC5834107/ /pubmed/28430855 http://dx.doi.org/10.1093/annonc/mdx181 Text en © The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Connell, C. M.
Raby, S.
Beh, I.
Flint, T. R.
Williams, E. H.
Fearon, D. T.
Jodrell, D. I.
Janowitz, T.
Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
title Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
title_full Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
title_fullStr Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
title_full_unstemmed Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
title_short Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
title_sort cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834107/
https://www.ncbi.nlm.nih.gov/pubmed/28430855
http://dx.doi.org/10.1093/annonc/mdx181
work_keys_str_mv AT connellcm cancerimmunotherapytrialregistrationsincreaseexponentiallybutchronicimmunosuppressiveglucocorticoidtherapymaycompromiseoutcomes
AT rabys cancerimmunotherapytrialregistrationsincreaseexponentiallybutchronicimmunosuppressiveglucocorticoidtherapymaycompromiseoutcomes
AT behi cancerimmunotherapytrialregistrationsincreaseexponentiallybutchronicimmunosuppressiveglucocorticoidtherapymaycompromiseoutcomes
AT flinttr cancerimmunotherapytrialregistrationsincreaseexponentiallybutchronicimmunosuppressiveglucocorticoidtherapymaycompromiseoutcomes
AT williamseh cancerimmunotherapytrialregistrationsincreaseexponentiallybutchronicimmunosuppressiveglucocorticoidtherapymaycompromiseoutcomes
AT fearondt cancerimmunotherapytrialregistrationsincreaseexponentiallybutchronicimmunosuppressiveglucocorticoidtherapymaycompromiseoutcomes
AT jodrelldi cancerimmunotherapytrialregistrationsincreaseexponentiallybutchronicimmunosuppressiveglucocorticoidtherapymaycompromiseoutcomes
AT janowitzt cancerimmunotherapytrialregistrationsincreaseexponentiallybutchronicimmunosuppressiveglucocorticoidtherapymaycompromiseoutcomes